Cordis

Focus: Cordis is a 5,000+ person medical device company headquartered in Miami Lakes, FL, focused on cardiovascular, respiratory, and nephrology interventions. The company operates as a public-stage entity with a robust pipeline centered on drug-eluting stents and endovascular therapies.

Cardiovascular Respiratory Nephrology

Profile data last refreshed 18h ago · AI intelligence enriched 2w ago

Funding Stage

PUBLIC

Employees

5000+

Open Jobs

About Cordis

AI assessmentNot Hiring

No open roles listed right now. Follow Cordis to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

3/9 — Basic

Company HealthSolid

Pipeline

Early-stage

50 total

LOE Risk

Protected

No near-term cliffs

Hiring

Stable

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

SELUTION SLR 014 DEB

Coronary Restenosis

N/A

Clinical Trials (1)

NCT04280029SELUTION SLR™ 014 In-stent Restenosis

N/A

Help build intelligence for Cordis

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Established 5,000+ person company with public-stage stability and Miami headquarters location
Deep cardiovascular device portfolio with multiple Phase 3/4 programs across coronary, peripheral, and aortic indications
Diversified pipeline spanning drug-eluting stents, balloon angioplasty, and endovascular repair technologies with established market applications

Watch Out For

Zero active job postings at time of analysis signals potential hiring freeze or organizational restructuring
No disclosed financial data (revenue, R&D spend, cash position) limits ability to assess runway or investment capacity for career growth

Generated by Claude from Cordis's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

VerifyNow French Registry

Stent Thrombosis

N/A

Cynergy: the CYPHER-NEVO Registry

Coronary Artery Disease

N/A

Clinical Trials (1)

NCT01106378Cynergy: the CYPHER-NEVO Registry

N/A

PCI with SELUTION SLR DCB

Coronary Artery Disease

N/A

Clinical Trials (1)

NCT05946629SELUTION 4 De Novo Small Vessel IDE Trial

N/A

Exoseal closure device

Coronary Disease

N/A

Open surgical revascularization

Critical Limb Ischemia

N/A

PMCF Study for Peripheral Arteries Above the Knee (ATK)

Peripheral Arterial Disease

N/A

Clinical Trials (1)

NCT05312580PMCF Study for Peripheral Arteries Above the Knee (ATK)

N/A

S.M.A.R.T.™ Nitinol Stent System

Superficial Femoral Artery Stenosis

N/A

Clinical Trials (1)

NCT07338890Post-Market Clinical Follow-Up of S.M.A.R.T. Family of Stents in Treating Iliac and Femoropopliteal Artery Disease

N/A

Biofreedom drug-coated stent

Coronary Artery Disease Aggravated

N/A

Clinical Trials (1)

NCT03045848Biofreedom Prospective Multicenter Observational Registry

N/A

Endovascular abdominal aortic aneurysm repair

Abdominal Aortic Aneurysms

N/A

Clinical Trials (1)

NCT02477111European (EU) Post Approval Study of the INCRAFT® AAA Stent Graft System in Subjects With Abdominal Aortic Aneurysms

N/A

FlexStent® Femoropopliteal Self Expanding Stent System

Peripheral Artery Disease

N/A

Clinical Trials (1)

NCT01355406Evaluation of Safety and Efficacy of the FlexStent® Femoropopliteal Self-Expanding Stent System

N/A

PMCF Study for Peripheral Arteries Below the Knee (BTK)

Peripheral Artery Disease

N/A

Clinical Trials (1)

NCT05444660PMCF Study for Peripheral Arteries Below the Knee (BTK)

N/A

Endovascular AAA repair

Abdominal Aortic Aneurysm

N/A

Clinical Trials (1)

NCT01776450Compassionate Use of the Incraft® AAA Stent Graft System

N/A

Sirolimus-Eluting Bx Velocity Coronary Stent

Coronary Artery Disease

N/A

Clinical Trials (1)

NCT00714623The SCRIPPS DES REAL WORLD Registry

N/A

PRECISE PRO Rx Nitinol Stent System

Carotid Artery Stenosis

N/A

Clinical Trials (1)

NCT07204678PMCF Study of Precise Pro Rx for Carotid Artery Disease

N/A

Cypher Stent

Cardiovascular Diseases

N/A

Clinical Trials (1)

NCT00489320An Observational Registry Using Drug Eluting Stents (DES) in Patients in a Real-World Setting (DEScover Registry).

N/A

NEVO™ Sirolimus-eluting Coronary Stent System

Coronary Atherosclerosis

N/A

Clinical Trials (1)

NCT00606333Comparison of the Conor Sirolimus-eluting Coronary Stent to the Taxus Liberte Paclitaxel-eluting Coronary Stent in the Treatment of Coronary Artery Lesions

N/A

kissing balloon inflation

Ischemic Heart Disease

N/A

Adroit Guiding Catheter, Cordis Transradial Access Devices, Cordis Diagnostic Catheters, Cordis Guidewires

Coronary Artery Disease

N/A

Clinical Trials (1)

NCT05543096PMCF Study for Cardiology Access Procedures

N/A

SELUTION SLR™ DEB 014

Peripheral Arterial Disease

N/A

Clinical Trials (1)

NCT05055297SELUTION4BTK Trial

N/A

S.M.A.R.T. RADIANZ™ Vascular Stent System

Peripheral Arterial Disease

N/A

Clinical Trials (1)

NCT05399680Evaluation of Safety and Efficacy of the S.M.A.R.T. RADIANZ™ Vascular Stent System in the Treatment of Iliac and Femoropopliteal Lesions Via Transradial Access

N/A

SELUTION SLR™ 018 DEB

Peripheral Arterial Disease

N/A

Clinical Trials (1)

NCT05132361SELUTION4SFA Trial

N/A

Stenting and minimally invasive bypass surgery

Coronary Artery Disease

N/A

Clinical Trials (1)

NCT00299429MIDCAB Versus DES in Proximal LAD Lesions

N/A

CYPHER® ELITE™ Sirolimus-Eluting Stent System

Coronary Artery Disease

N/A

Clinical Trials (1)

NCT00715884Study Comparing the CYPHER® ELITE™ to the CYPHER® Bx VELOCITY® Sirolimus-Eluting Stent Systems

N/A

MYNX CONTROLTM VENOUS Vascular Closure Device

Venous Vascular Closure

N/A

Clinical Trials (1)

NCT07246902Mobilization and Outcomes After Venous Closure

N/A

IVC Filter

Pulmonary Embolism

N/A

Cordis AAA stent graft system "INCRAFT TM"

Abdominal Aortic Aneurysms

N/A

Clinical Trials (1)

NCT01106391A Multicenter, Open Label, Prospective, Non-Randomized Study Of INCRAFT™ In Subjects With AAA (INNOVATION)

N/A

MYNX CONTROL™ Venous Vascular Closure Device 6F-12F

Venous Vascular Closure

N/A

Clinical Trials (1)

NCT05554471Evaluation of Safety and Efficacy of the Mynx Control Venous Vascular Closure Device 6F-12F vs Manual Compression

N/A

Endovascular AAA repair with InCraft®

Abdominal Aortic Aneurysm

N/A

Clinical Trials (1)

NCT01664078A Multicenter, Open Label, Prospective, Non-randomized Study of the InCraft® Stent Graft System in Subjects With Abdominal Aortic Aneurysms (INSPIRATION)

N/A

S.M.A.R.T. ® Stent

Superficial Femoral Artery Disease

N/A

Clinical Trials (1)

NCT00739102S.M.A.R.T.® Nitinol Self-Expandable Stent in the Treatment of Obstructive Superficial Femoral Artery Disease

N/A

MynxGrip

Endovascular

N/A

SAPPHIRE Worldwide: Stenting and Angioplasty With Protection in Patients At High-Risk for Endarterec

Carotid Artery Disease

N/A

Clinical Trials (1)

NCT00403078SAPPHIRE Worldwide: Stenting and Angioplasty With Protection in Patients At High-Risk for Endarterectomy

N/A

CYPHER® Bx Velocity™ stent

Coronary Stenosis

N/A

Clinical Trials (1)

NCT00403338The Impact of Stent Deployment Techniques on Clinical Outcomes of Patient Treated With the CYPHER® Stent (S.T.L.L.R.)

N/A

Economic Evaluation German Drug-Eluting Stent Registry

Coronary Heart Disease

N/A

Clinical Trials (1)

NCT00866398Economic Evaluation German Drug-Eluting Stent Registry

N/A

PALMAZ MULLINS XD™ Pulmonary Stent

Pulmonary Artery Stenosis

N/A

Clinical Trials (1)

NCT07122518Post-Approval Study of PALMAZ MULLINS XD™ in Treating Pulmonary Artery Stenosis

N/A

INCRAFT

Abdominal Aortic Aneurysms

N/A

Clinical Trials (1)

NCT03965364China Post-market Study of the INCRAFT® AAA Stent Graft System in Subjects With Abdominal Aortic Aneurysms (INITIATION)

N/A

Epinephrine

Anaphylactic Reaction

PHASE_1

Clinical Trials (1)

NCT06013150Study of Inhaled DMC-IH1 and Intramuscular (EpiPen®) Epinephrine in Healthy Male and Female Participants.

Phase 1

EpiPen ®.

Anaphylactic Reaction

PHASE_1

Clinical Trials (1)

NCT05152901Study of Inhaled Epinephrine and Intramuscular Epinephrine Administered to Healthy Adults

Phase 1

7F Ensure Medical Vascular Closure Device

Angioplasty, Transluminal, Percutaneous Coronary

PHASE_1

Clinical Trials (1)

NCT00574691ECLIPSE Feasibility Trial (Ensure's Vascular Closure Device Speeds Hemostasis Trial) EU

Phase 1

sirolimus coated Bx VELOCITY stent - fast release

Coronary Artery Disease

PHASE_1_2

Clinical Trials (1)

NCT00233792FIM-BR - First-in-Man Study (Brazil Part) With Sirolimus-Coated BX VELOCITY Stent

Phase 1/2

Sirolimus-coated Bx VELOCITY Stent

Coronary Artery Disease

PHASE_1_2

Clinical Trials (1)

NCT00233818FIM-NL - First-in-Man Study (Netherlands Part) With Sirolimus Coated Modified BX Velocity Stent

Phase 1/2

Cordis AAA Bilateral Device

Abdominal Aortic Aneurysm

PHASE_1_2

Clinical Trials (1)

NCT00235118Cordis Bilateral AAA Device Compared to Open Surgical Repair of Abdominal Aortic Aneurysms (ARIBA)

Phase 1/2

Sirolimus-Eluting BX Velocity Balloon-Expandable Stent

Peripheral Vascular Diseases

PHASE_1_2

Clinical Trials (1)

NCT00489164Feasibility Study With the Sirolimus-Eluting BX Velocity Balloon-Expandable Stent in the Treatment of Diabetic Patients With Native Coronary Artery Lesions

Phase 1/2

GAMMA-Iridium-192 catheter

Coronary Artery Disease

PHASE_1_2

Clinical Trials (1)

NCT00232778A Multicenter Trial of Localized Radiation Therapy to Inhibit Restenosis (GAMMA V)

Phase 1/2

Bx VELOCITY Stent containing 45% and 70% of Sirolimus dose

Coronary Artery Disease

PHASE_1_2

Clinical Trials (1)

NCT00233766Evaluation of Two Reduced Sirolimus Doses in Treatment of de Novo Coronary Artery Lesions (REDOX)

Phase 1/2

CYPHER Sirolimus-Eluting Coronary Stent

Coronary Artery Disease

PHASE_1_2

Clinical Trials (1)

NCT00233714Double or Single Dose Sirolimus-Eluting Stents in Diabetic Patients With de Novo Coronary Artery Lesions

Phase 1/2

Sirolimus-eluting Palmaz Genesis peripheral stent

Renal Artery Stenosis

PHASE_2

Clinical Trials (1)

NCT00235157A Comparison of Coated and Uncoated Stents in Renal Artery Treatment.

Phase 2

drug-eluting stent

Peripheral Artery Disease

PHASE_2

Clinical Trials (1)

NCT00232869A Study of the SMART Stent in the Treatment SFA Disease.

Phase 2

SIROLIMUS-ELUTING, HEPARIN-COATED CoCr BALLOON-EXPANDABLE STENT

Coronary Artery Disease

PHASE_2

Clinical Trials (1)

NCT00233779Evaluation of Sirolimus-Eluting, Heparin-Coated CoCr Stent in the Treatment of de Novo Coronary Artery Lesions in Small Vessels(EVOLUTION)

Phase 2

Sirolimus coated Bx Velocity™

Coronary Artery Disease

PHASE_2

Clinical Trials (1)

NCT00233805The Initial Double-Blind Drug-Eluting Stent vs Bare-Metal Stent Study.

Phase 2

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts

Founded: 2022

Portfolio: 99 clinical trials

Top TAs: Cardiovascular, Respiratory, Nephrology

Publications: 25 in PubMed

Therapeutic Area Focus

Cardiovascular

69 pipeline

Respiratory

2 pipeline

Nephrology

1 pipeline

Marketed

Pipeline

Hiring Trend

Stable

Open Roles

Added

-0

Filled/Removed

Based on last 4 crawl cycles

Research Publications(10)

Recent peer-reviewed publications with author affiliations at this company

A Phase III Randomized Controlled Trial Evaluating the Efficacy and Safety of Azilsartan Medoxomil and Amlodipine Combination Therapy in Patients With Mild-to-Moderate Essential Hypertension Inadequately Controlled on Monotherapy.

Clinical therapeutics

2026

PMID:40945998

Corrigendum to 'Intravascular Coronary Imaging' Journal of the Society for Cardiovascular Angiography & Interventions 3;12 (2024) 102399.

Journal of the Society for Cardiovascular Angiography & Interventions

2025

PMID:40630245